Advances in the Radiological Evaluation of and Theranostics for Glioblastoma

Authors

Grayson W Hooper
Shehbaz Ansari
Jason M Johnson
Daniel T Ginat

Publication Date

8-18-2023

Journal

Cancers

Abstract

Imaging is essential for evaluating patients with glioblastoma. Traditionally a multimodality undertaking, CT, including CT cerebral blood profusion, PET/CT with traditional fluorine-18 fluorodeoxyglucose (18F-FDG), and MRI have been the mainstays for diagnosis and post-therapeutic assessment. However, recent advances in these modalities, in league with the emerging fields of radiomics and theranostics, may prove helpful in improving diagnostic accuracy and treating the disease.

Keywords

glioblastoma, GBM, glioma, high-grade glioma, CT, MRI, PET, theranostics, radiomics

Comments

Data Availability Statement

PMID: 37627190

DOI

10.3390/cancers15164162

PMID

37627190

PMCID

PMC10453051

PubMedCentral® Posted Date

August 2023

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes